The study, published in JAMA Network Open, provides important insights into the long-term impacts of severe respiratory infections on patient health.
The research, led by Dr. Junqing Xie from NDORMS, looked at data from 190,000 participants from the UK Biobank, categorising them into three groups: those hospitalised with COVID-19, those hospitalised with other lower respiratory tract infections (LRTIs), and a reference group with no LRTI hospitalisations. Participants completed surveys reporting on 45 different physical and psychological symptoms.
‘Our findings show that the post-acute effects of COVID-19 are not unique - they can also occur with other severe respiratory infections,’ explained Junqing. ‘Patients hospitalised with COVID-19 saw higher risks of 23 out of 45 symptoms observed across multiple bodily systems, so do 18 out of 45 for patients hospitalised for non-COVID LRTIs.
Although previous studies have shown that COVID-19 patients may have persistent ageusia (loss of taste) or severe fatigue, one of the main concerns arising from this study are the neurological and cognitive symptoms also observed. For example, problems with thinking and communicating are not only higher than in the reference group, but also than those hospitalised for other LRTIs.
‘As healthcare systems continue to grapple with the after-effects of the COVID-19 pandemic, it's critical that we expand our understanding of long-term health consequences that can arise from other severe respiratory infections,’ said Junqing. ‘Also, by recognising differences/similarities between PAIS caused by a different virus, we can plan better preventive measures and tailored care for these patients.’